ArticleCellular & molecular immunology2018

A modified HLA-A*0201-restricted CTL epitope from human oncoprotein (hPEBP4) induces more efficient antitumor responses.

Weihong Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.